DCNH 2020

15-16 September 2021
NEC, Birmingham


 Home Care ExpoEuropean Neuro ConventionCPD Member



Painchek UK Limited

Stand: E50
`Our purpose is to give a voice to people who cannot verbalise their pain.` Learn how to consistently assess pain in those with Dementia or Alzheimer's Disease. PainChek® is the world`s first pain assessment tool that has regulatory clearance in Australia and Europe. Using AI and facial recognition technology, PainChek® provides carers across multiple clinical areas with three important new clinical benefits: 1. The ability to identify the presence of pain, when pain isn`t obvious 2. To quantify the severity level of pain, when pain is obvious, and; 3. To monitor the impact of treatment to optimise overall care Every care home in the UK that provides services to those that have dementia or Alzheimer's should be using this tool to assess and manage pain. Pain is common: Up to 80% of people in aged care experience chronic pain. But pain often goes undetected and untreated. Pain is difficult to assess. Tools to assess pain are often not used or use subjective rating scales. Accurately identifying pain can: - Improve quality of life - Reduce rates and severity of behavioural and psychological symptoms of dementia - Reduce rates of incorrectly prescribed antipsychotics - Improve staff retention


10 John Street
United Kingdom
Visit website

Contact Exhibitor

View all Exhibitors

The Workforce of Tomorrow

Wednesday 27th January

The care sector have shown true strength, resilience and adaptiveness in their COVID-19 response, but as we look towards the future, what can be done to support a workforce under such pressures?

Find out more here